Getting ahead of cancer: SPECT/Spiral CT technology enhances bone scanning, earlier diagnosis

June 05, 2006

SAN DIEGO, Calif.--New imaging technology--the use of single photon emission tomography (SPECT) with spiral computed tomography (CT) scanners--creates high quality images that enhance detection of cancer in patients, according to results presented at SNM's 53rd Annual Meeting June 3-7 in San Diego.

"The specificity of bone scintigraphy--or bone scanning--is enhanced by combining SPECT with spiral CT," explained Wolfgang Römer, assistant professor and vice chair of the Clinic of Nuclear Medicine at the University of Erlangen/Nuremberg in Germany. "Because of this technology, the diagnostic process is shortened, reducing stress considerably for individuals waiting for a definite diagnosis," added the co-author of "Diagnostic Value of Tc-99m-DPD-SPECT/Spiral-CT Hybrid Imaging in Unclear Foci of Increased Bone Metabolism in Cancer Patients."

Römer said, "With SPECT/CT, the morphologic correlate (form and structure) can be visualized to further clarify findings on bone scintigraphy. We call our procedure 'SPECT-guided CT.' " He further explained, "From our study, we conclude that SPECT-guided CT is able to clarify more than 90 percent of findings that were classified as indeterminate in the analysis of SPECT alone. That could mean that in daily clinical practice, additional radiological examinations can be avoided in 90 percent of patients with indeterminate findings in bone scintigraphy." The German researchers also significantly reduced the CT radiation exposure, according to the study that Römer calls the first report on the benefit of SPECT/spiral CT in bone scintigraphy.

The combination of SPECT and CT was introduced about five years ago but provided non-diagnostic quality CT images, said Römer. "The recently introduced combination of SPECT and spiral CT scanners enables combined SPECT/CT images, which are diagnostic," he detailed. "With bone scintigraphy alone, it is not possible to differentiate bone metastases (spread) from benign processes causing enhanced bone metabolism," said Römer. Consequently, additional radiological examinations are regularly recommended to study the metabolic changes. These studies are performed separately and--most often--with a certain time delay, said the nuclear medicine physician and board-certified radiologist. In addition, a radiologist analyzing the separate CT examination may not have detailed information on the scintigraphic findings.

Bone scintigraphy reveals changes in bone metabolism rather than changes in bone structure. The tracer usually requires several hours to be absorbed into the bone and cleared from the remaining tissues of the body. By evaluating the images taken at different times after the administration of the tracer, information about bone metabolism and blood flow versus soft tissue (muscle, ligament, tendon) can be obtained. Spiral CT scanning is a painless procedure in which a special imaging machine rotates rapidly around the body, taking cross-sectional images. The term "spiral CT" comes from the shape of the path taken by the X-ray beam during scanning. The German researchers used the SPECT/CT system Symbia T2, provided by Siemens Medical Solutions for scientific evaluation.

Römer indicated that the number of patients included in the study was limited, and additional studies with larger patient populations should carefully address the cost efficiency of this new technology and its value in a real clinical setting.
Abstract: W. Römer, A. Noemayr and T. Kuwert, Clinic of Nuclear Medicine, University of Erlangen/Nuremberg, Erlangen, Germany; M. Uder and W. Bautz, Institute of Radiology, University of Erlangen/Nuremberg, Erlangen, Germany, "Diagnostic Value of Tc-99m-DPD-SPECT/Spiral-CT Hybrid Imaging in Unclear Foci of Increased Bone Metabolism in Cancer Patients," SNM's 53rd Annual Meeting, June 3-7, 2006, Scientific Paper 251.

About SNM

SNM is holding its 53rd Annual Meeting June 3-7 at the San Diego Convention Center. Research topics for the 2006 meeting include molecular imaging in clinical practice in the fight against cancer; the role of diagnostic imaging in the management of metastatic bone disease, metabolic imaging for heart disease, neuroendocrine and brain imaging, new agents for imaging infection and inflammation, and an examination of dementia, neurodegeneration, movement disorders and thyroid cancer.

SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed resource in the field; sponsor research grants, fellowships and awards; host the premier annual meeting for medical imaging; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at

Society of Nuclear Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to